[{"id":"9669087f-ea2d-4d1d-88be-fc095cacb995","acronym":"","url":"https://clinicaltrials.gov/study/NCT04993391","created_at":"2021-08-06T13:53:19.964Z","updated_at":"2024-07-02T16:36:01.841Z","phase":"Phase 1/2","brief_title":"AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer","source_id_and_acronym":"NCT04993391","lead_sponsor":"Suzhou Junjing BioSciences Co., Ltd.","biomarkers":" EGFR","pipe":" | ","alterations":" EGFR mutation • EGFR exon 20 insertion • EGFR exon 20 mutation","tags":["EGFR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR mutation • EGFR exon 20 insertion • EGFR exon 20 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e JS111"],"overall_status":"Recruiting","enrollment":" Enrollment 156","initiation":"Initiation: 07/13/2021","start_date":" 07/13/2021","primary_txt":" Primary completion: 06/18/2024","primary_completion_date":" 06/18/2024","study_txt":" Completion: 08/18/2024","study_completion_date":" 08/18/2024","last_update_posted":"2022-10-26"}]